MNPR
Price
$17.83
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
QNCX
Price
$0.99
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
3 days until earnings call
Ad is loading...

MNPR vs QNCX

Header iconMNPR vs QNCX Comparison
Open Charts MNPR vs QNCXBanner chart's image
Monopar Therapeutics
Price$17.83
Change-$0.00 (-0.00%)
Volume$2.36M
CapitalizationN/A
Quince Therapeutics
Price$0.99
Change-$0.00 (-0.00%)
Volume$408.79K
CapitalizationN/A
View a ticker or compare two or three
MNPR vs QNCX Comparison Chart
Loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MNPR vs. QNCX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNPR is a Buy and QNCX is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (MNPR: $17.83 vs. QNCX: $0.99)
Brand notoriety: MNPR and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNPR: 136% vs. QNCX: 154%
Market capitalization -- MNPR: $23.64M vs. QNCX: $33.54M
MNPR [@Biotechnology] is valued at $23.64M. QNCX’s [@Biotechnology] market capitalization is $33.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNPR’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 1 green FA rating(s).

  • MNPR’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 1 green, 4 red.
According to our system of comparison, both MNPR and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNPR’s TA Score shows that 5 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • MNPR’s TA Score: 5 bullish, 4 bearish.
  • QNCX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MNPR is a better buy in the short-term than QNCX.

Price Growth

MNPR (@Biotechnology) experienced а +239.62% price change this week, while QNCX (@Biotechnology) price change was +21.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MNPR is expected to report earnings on Nov 07, 2024.

QNCX is expected to report earnings on Nov 01, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNCX($33.5M) has a higher market cap than MNPR($23.6M). MNPR YTD gains are higher at: 948.207 vs. QNCX (-5.562). MNPR has higher annual earnings (EBITDA): -7.49M vs. QNCX (-31.63M). QNCX has more cash in the bank: 59.4M vs. MNPR (7.12M). MNPR has less debt than QNCX: MNPR (0) vs QNCX (14.4M). MNPR (0) and QNCX (0) have equivalent revenues.
MNPRQNCXMNPR / QNCX
Capitalization23.6M33.5M70%
EBITDA-7.49M-31.63M24%
Gain YTD948.207-5.562-17,048%
P/E RatioN/AN/A-
Revenue00-
Total Cash7.12M59.4M12%
Total Debt014.4M-
TECHNICAL ANALYSIS
Technical Analysis
MNPRQNCX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

MNPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with QNCX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
+5.32%
QNCX - MNPR
43%
Loosely correlated
-8.19%
AKBLF - MNPR
29%
Poorly correlated
N/A
LOGC - MNPR
28%
Poorly correlated
+2.65%
BDRX - MNPR
26%
Poorly correlated
+3.17%
DOSEF - MNPR
24%
Poorly correlated
N/A
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-8.19%
MNPR - QNCX
43%
Loosely correlated
+5.32%
CCCC - QNCX
33%
Poorly correlated
+1.87%
HSTO - QNCX
31%
Poorly correlated
N/A
ADCT - QNCX
31%
Poorly correlated
+3.73%
CLNN - QNCX
29%
Poorly correlated
+9.72%
More